Daehan Nupharm Co.,Ltd. (KOSDAQ:054670)
South Korea · Delayed Price · Currency is KRW 5,030.00
-10.00 (-0.20%)
At close: Nov 13, 2026
Daehan Nupharm Market Cap
Daehan Nupharm has a market cap or net worth of 70.6 billion as of November 13, 2026. It is the 29,457th most valuable company in the world and the 1,476th biggest in South Korea. Its market cap has decreased by 24.36% in one year.
Market Cap
70.60B
Enterprise Value
133.93B
Revenue
211.48B
Global Rank
Country Rank
#1,476 South Korea
PE Ratio
2.95
ChartMarket Cap Chart
Since March 3, 2003, Daehan Nupharm's market cap has increased from 13.03B to 70.60B, an increase of 441.72%. That is a compound annual growth rate of 7.38%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 70.60B | -23.44% |
| Dec 30, 2025 | 92.21B | -4.37% |
| Dec 30, 2024 | 96.42B | -24.09% |
| Dec 28, 2023 | 127.02B | 5.97% |
| Dec 29, 2022 | 119.86B | -21.65% |
| Dec 30, 2021 | 152.98B | -13.49% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| WITHUS PHARMACEUTICAL Co.,LTD. | 89.49B |
| KOREA PHARMA | 87.25B |
| Samik Pharmaceutical Company LTD. | 85.98B |
| Cosmax Nbt | 81.40B |
| Pharos iBio | 80.39B |
| Sam-A Pharm. | 78.61B |
| H.PIO | 78.18B |
| Sinil Pharmaceutical | 72.58B |